A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy Participants
AstraZeneca
AstraZeneca
Murdoch Childrens Research Institute
Mirati Therapeutics Inc.
Eli Lilly and Company
Canadian Cancer Trials Group
Mayo Clinic
Genentech, Inc.
National Cancer Institute (NCI)
Janssen Research & Development, LLC
Rutgers, The State University of New Jersey